What Trials24 does

Trials24 is a Munich, Germany-based, privately-held for-profit company founded in 2017 that operates in the online patient recruitment segment of the clinical-trial services market. According to its firmographic profile, Trials24 accelerates patient recruitment for clinical trials worldwide with an explicit mission to help study sites find patients they otherwise cannot reach, targeting the well-documented enrollment bottleneck where the majority of clinical trials miss recruitment timelines. The company reports a headcount of 11-50 employees, consistent with an early-to-mid stage commercial operation, and its primary web presence is at trials24.com.

Publicly disclosed detail on Trials24's specific product suite, underlying technology stack, pricing, customer roster, partnership network, and revenue trajectory is not present in the source material. The bulk of the aggregated source data set describes SubjectWell (subjectwell.com) — a separate, materially larger patient-recruitment platform — rather than Trials24, and that operational profile cannot be attributed to Trials24 without further confirmation. The lone directly-attributable technological signal for Trials24 is the use of AI-powered agents to screen patients, verify eligibility, and facilitate scheduling within clinical-trial recruitment workflows, indicating AI is embedded as a workflow-level feature rather than a proprietary foundation.

Trials24's go-to-market is consistent with a direct B2B sales motion targeting sponsors, contract research organizations (CROs), and investigative sites — a standard commercial pattern for this category — but no specific customer logos, contract sizes, or sales channels are documented. Trial24's reported leadership includes a Marketing and Communications Manager (Bohdana Demianenko); no further executive or board detail is provided.

Name

Trials24

Website

https://trials24.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Trials24 is a Munich-based privately-held company founded in 2017 that provides online patient recruitment services for clinical trials worldwide, helping study sites find patients they cannot otherwise reach.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Recruitment Technology

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Patient Recruitment & Retention (HLAGACAD)

akta.pro secondary industries

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Patient Recruitment, Retention & Engagement for Trials (HLACAOAK)

Keywords

• Clinical trial recruitment
• Patient recruitment services
• Clinical research technology
• Patient recruitment platform
• Site enablement services

Headquarters

HQ city

München

HQ country

Germany

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Patient Recruitment Services: Provides patient recruitment solutions to sponsors, CROs, and sites. Services include full-site support, patient care and trial retention, virtual waiting room, recruitment simulation, secondary screening, and translations.
2. Commercial Solutions: Brand Connect solutions enabling brand marketers and agencies to leverage engaged patient populations for direct product marketing.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Trials24 accelerates online patient recruitment for clinical trials by connecting sponsors, CROs, and clinical sites with a 15 million+ patient network and AI-driven screening tools. It supplements this software platform with clinically trained, multilingual Patient Companions who handle administrative support, eligibility phone screening, transportation logistics, medical records retrieval, scheduling, and retention outreach. Additional services cover virtual waiting room management, recruitment simulation, secondary screening, and translations of IRB/EC-approved recruitment materials.

Product overview

SubjectWell offers a unified platform-plus-services architecture centered on the SubjectWell+ Platform, a comprehensive patient recruitment and site enablement solution. The platform integrates with multiple service modules including Study Connect and Direct Connect for patient recruitment, and Brand Connect for commercial marketing. Supporting these are complementary services such as Full-Site Support, Patient Care & Trial Retention, Virtual Waiting Room, Recruitment Simulation, Secondary Screening, and Translations, all delivered through clinically trained Patient Companions and designed to reduce site and patient burden throughout the clinical trial lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• SubjectWell+ Platform Core technology platform for clinical trial patient recruitment and site enablement, combining the 15M+ Patient Network, AI-driven screening, eligibility verification, scheduling, and integrated service modules for sponsors, CROs, and sites.
• Full-Site Support Standalone service relieving site administrative burden through Patient Companions who handle patient communication, transportation logistics, medical records retrieval and review, phone screening for eligibility assessment, and site visit scheduling.
• Patient Care & Trial Retention End-to-end service supporting patients throughout the clinical trial process through study close, ensuring patient engagement and retention across the trial lifecycle.
• Virtual Waiting Room Service that keeps patients engaged and prepared when sites are overloaded or not yet ready, managing complex dependencies such as CAR-T, lab results, or flare-ups while reducing dropouts.
• Recruitment Simulation Service that gathers insights to improve the patient experience during the patient recruitment process for clinical trials.
• Secondary Screening Service that reduces site effort and time by having Patient Companions schedule the site screening call for patients.
• Translations Translation service for IRB/EC-approved English trial recruitment materials into required languages to support global and multi-country study onboarding.

Quantifiable outcome

• 30% enrollment acceleration potential
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Site NetworkscoreStrategic or Co-development PartnerStrategic partnerships with site networks to streamline patient enrollment and reduce site burden. SubjectWell supports these networks with their technology platform and patient recruitment services.
• CRO PartnerscoreStrategic or Co-development PartnerPartnerships with Contract Research Organizations to integrate patient recruitment services seamlessly with CRO operational processes and accelerate study timelines.

Scale indicators12 records

Emerging players

• Mendel.ai: Mendel.ai applies AI/structured-data extraction to clinical-trial patient matching, representing an emerging AI-native competitor whose technology trajectory could overlap with Trials24's recruitment workflow.
• Deep 6 AI: Deep 6 AI uses AI to mine structured and unstructured EHR data for clinical-trial patient identification, intersecting with Trials24's mission via a more technology-centric, less service-heavy approach.

Broad incumbents

• Parexel: Parexel is a global CRO with integrated patient-recruitment services within its full-service clinical trial offerings, directly contesting Trials24's positioning at enterprise sponsor accounts.
• IQVIA: IQVIA is a global full-service CRO that includes patient recruitment as part of its broader clinical operations portfolio, representing a major incumbent that competes at the sponsor level against Trials24.

Direct peers

• Clariness: Clariness is a Hamburg-based clinical trial patient recruitment company with a comparable European footprint and sponsor base, making it the closest geographic and service-line peer to Trials24.
• Antidote: Antidote is a digital patient-recruitment company using structured matching to connect patients to clinical trials, providing directly comparable online recruitment services to Trials24's offerings.
• SubjectWell: SubjectWell operates a 15M+ patient network and a SubjectWell+ platform for clinical-trial patient recruitment, addressing the same problem as Trials24 and serving the same sponsor/CRO/site buyer base.
• BBK Worldwide: BBK Worldwide is an established patient-recruitment and engagement agency serving global trials, with overlapping services (referral, retention, site support) and a comparable sponsor customer base to Trials24.

Market position

Strengths4 records

Weaknesses4 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trials24